Search results
14 lis 2022 · Current guidelines governed by the Infectious Diseases Society of America (IDSA) recommend vancomycin (VAN) or daptomycin (DAP) as first-line agents for treating MRSA bacteremia (MRSA). While both have proved to be efficacious, neither is without limitations [6].
- Management of Staphylococcus aureus Bloodstream Infections
A structured management in diagnostic and treatment is...
- Management of Staphylococcus aureus Bloodstream Infections
1 lut 2011 · The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections.
5 mar 2021 · A structured management in diagnostic and treatment is crucial for an optimal outcome. Several studies have shown that an adherence to treatment guidelines and particularly infectious disease bedside-consultation can lead to a reduction of mortality by up to 50% (10–12).
1 lut 2011 · For health care–associated MRSA (HA-MRSA) or CA-MRSA pneumonia, IV vancomycin (A-II) or linezolid 600 mg PO/IV twice daily (A-II) or clindamycin 600 mg PO/IV 3 times daily (B-III), if the strain is susceptible, is recommended for 7–21 days, depending on the extent of infection.
Staphylococcus aureus Bloodstream Infection Treatment Guideline. Purpose: To provide a framework for the evaluation and management patients with Methicillin-Susceptible (MSSA) and Methicillin-Resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI). The recommendations below are guidelines for care and are not meant to replace ...
22 kwi 2022 · The choice of the optimal antibiotic treatment of S. aureus ABSSSI for any given patient depends on several parameters related to the microorganism, the disease, the patient, and the drug: (i) methicillin resistance; (ii) severity of clinical presentation; (iii) baseline comorbidities; (iv) possible allergies; (v) adherence to treatment; (vi) ne...
27 lis 2023 · IDSA MRSA Treatment Guidelines recommend vancomycin or daptomycin as first-line therapy for methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI). Limited data and few recommendations exist regarding combination treatment for MRSA BSI outside of prosthetic valve endocarditis (PVE).
